Where it is registered
Each register and historical list with its number of registrations and a few of them.
Brazil
Anvisa · 1 registration
Canada
Health Canada · 1 registration
Spain
AEMPS · 1 registration
European Union
EMA · 1 registration
Croatia
HALMED · 1 registration
Netherlands
CBG-MEB · 1 registration
Singapore
HSA · 1 registration
At a glance
- Registers
- 8
- Registrations
- 8
- With their own page
- 8
- Companies
- 6
All medicines with Relatlimab
Human medicines from every register that match Relatlimab by substance or by name, a page at a time, so the count can differ from the registrations above. Strengths and packs are on each medicine’s page.
8 search results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| OpdualagCombination | European Union | Authorised | Bristol-Myers Squibb Pharma EEIG | ||
| OpdualagCombination | United States | 240MG; 80MG | solution | Marketed | Bristol Myers Squibb |
| Opdualag 240 MG/80 MG Concentrado Para Solucion Para PerfusionCombination | Spain | 85,20 mg + 255,60 mg | concentrado para solución para perfusión | Authorised | Bristol-Myers Squibb Pharma Eeig |
| Opdualag 80 mg/240 mg, concentraat voor oplossing voor infusieCombination | Netherlands | Concentraat voor oplossing voor infusie | Authorised | Bristol-Myers Squibb Pharma EEIG | |
| OpdualagCombination | Canada | 240 MG / 20 ML + 80 MG / 20 ML | Solution | Marketed | Bristol-Myers Squibb Canada |
| OpdualagCombination | Brazil | Authorised | Bristol-Myers Squibb Farmacêutica Ltda | ||
| Opdualag Concentrate for Solution for Infusion 240MG/80MGCombination | Singapore | 240mg per vial + 80mg per vial | infusion, solution concentrate | Authorised | Bristol-Myers Squibb (Singapore) Pte. LTD. |
| OpdualagCombination | Croatia | Authorised |



